CAT #: 23090050
BCL2/JH Tube A - Unlabeled
Master mixes are components of complete assays. Master mixes are composed of a buffered magnesium solution, deoxynucleotides, and multiple primers that target the gene segments of interest. Multiple primers are used to ensure a more comprehensive testing approach necessary to reliably identify clonal rearrangements. These tests are complete with the exception of Taq DNA Polymerase, which is not provided. A single thermocycler program and similar detection methods are used within each series of test to improve consistency, reduce human error, and facilitate cross training.
50µl Total PCR Reaction Volume:
- Using gloved hands, remove the master mixes from the freezer. Allow the tubes to thaw; then gently vortex to mix.
- In a containment hood or dead air box remove an appropriate aliquot to clean, sterile microfuge tube (one tube for each of the master mixes). Aliquot volumes should be 45µl for each sample + 135µl for the positive, negative and no template controls. We recommend adding an additional 20µl to correct for pipetting errors.
- Add the appropriate amount of either AmpliTaq Gold or AmpliTaq DNA polymerase (0.25µl of either AmpliTaq Gold or AmpliTaq @ 5U/µl per 50µl total PCR reaction volume) to each of the master mixes and gently mix by inverting several times or gently vortexing.
- Aliquot 45µl of master mix to individual wells of a PCR plate.
- Add 5µl of DNA from the unknown and control samples to individual tubes or wells containing the respective master mix reactions, and pipette up and down several times to mix. Amplify target DNA using the universal thermocycler program.
Historically, BCL2/JH t(14;18) Translocation Assays have been used to:
- Distinguish lymphoma from benign lymphoid hyperplasia
- Distinguish follicular lymphoma from other B-cell lymphomas that may have a similar appearance
- Monitor and evaluate disease recurrence and detect residual disease
- Specimen Requirements
This product tests genomic DNA. DNA can be extracted from the following specimens:
- 5cc of peripheral blood, bone marrow biopsy, or bone marrow aspirate anti-coagulated with heparin or EDTA; OR,
- Minimum 5mm cube of tissue shipped frozen, at room temperature, or on ice in RPMI 1640; OR,
- Formalin-fixed paraffin embedded tissue or slides.
The BCL2 t(14;18) (q32;q21) translocation is found in 80-90% of follicular lymphomas and 30% of diffuse large cell lymphomas. The translocation is rarely present in other lymphoproliferative diseases. The t(14;18) brings about juxtaposition of BCL2 with the Ig heavy chain joining segment. This leads to a marked increase in expression of BCL2 driven by the Ig heavy chain gene enhancer. The bcl-2 protein inhibits programmed cell death (apoptosis) leading to cell accumulation. The majority of breakpoints on 18q21-22 occur within the major breakpoint region (Mbr) in the 3′ untranslated region of exon 3 (60-70% of the cases), and the minor cluster (mcr) region located 3′ to BCL2 exon 3 (20-25% of the cases). Some breakpoints occur at distant loci and will not be identified by this particular test. Therefore, a negative result does not completely exclude the presence of a BCL2/IGH gene rearrangement in the sample. In comparison, Southern blot analysis requires 1-2 weeks, is significantly less sensitive, and has more restrictive specimen requirements. The performance characteristics of this product have been independently determined by the EuroClonality Group.
Four master mixes are included in this assay. Three are used to identify translocations in the major breakpoint region (Mbr) and minor cluster region (mcr) of BCL2. The Specimen Control Size Ladder master mix targets multiple genes and generates a series of amplicons of 100, 200, 300, 400, and 600 basepairs to ensure that the quality and quantity of input DNA is adequate to yield a valid result. This assay includes negative control DNA and positive control DNAs for both the Mbr and mcr. Clonality is indicated if any one of the master mixes generates clonal band(s). PCR products can be analyzed using standard gel electrophoresis with ethidium staining.
Warranty and Liability
Invivoscribe, Inc. (Invivoscribe®) is committed to providing the highest quality products. Invivoscribe® warrants that the products meet or exceed the performance standards described in the Instructions For Use, as to products with such an insert.If a product is covered by product specifications and does not perform as specified, our policy is to replace the product or credit the full purchase price. No other warranties of any kind, expressed or implied, are provided by Invivoscribe®. Invivoscribe® liability shall not exceed the purchase price of the product.Invivoscribe shall have no liability for direct, indirect, consequential or incidental damages arising from the use, results of use, or inability to use its products; product efficacy under purchaser controlled conditions in purchaser’s laboratory must be established and continually monitored through purchaser defined and controlled processes including but not limited to testing of internally validated positive, negative, and blank controls every time a sample is tested. Ordering, acceptance and use of product constitutes purchaser acceptance of sole responsibility for assuring product efficacy and purchaser agreement to the limitation of liability set forth in this paragraph.
This product is for Research Use Only; not for use in diagnostic procedures.
©2020 Invivoscribe, Inc. All rights reserved. The trademarks mentioned herein are the property of Invivoscribe, Inc. and/or its affiliates, or (as to the trademarks of others used herein) their respective owners.